Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Higher calcineurin inhibitor levels predict better kidney graft survival in patients with de novo donor-specific anti-HLA antibodies: a cohort study

Published:2017-03-05 Issue:5 Volume:30 Page:502-509
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Béland Marc-Antoine¹,Lapointe Isabelle¹,Noël Réal¹,Côté Isabelle¹,Wagner Eric²,Riopel Julie³,Latulippe Eva³,Désy Olivier¹,Béland Stéphanie¹,Magee Ciara N.⁴,Houde Isabelle¹,De Serres Sacha A.¹^ORCID

Affiliation:

1. Transplantation Unit; Renal Division; Department of Medicine; Faculty of Medicine; University Health Center of Quebec; Laval University; Quebec QC Canada

2. Immunology and Histocompatibility Laboratory; Faculty of Medicine; University Health Center of Quebec; Laval University; Quebec QC Canada

3. Department of Pathology; Faculty of Medicine; University Health Center of Quebec; Laval University; Quebec QC Canada

4. Department of Nephrology & Renal Transplantation; UCL Centre for Nephrology; Royal Free London NHS Foundation Trust; London UK

Funder

Canadian Institutes of Health Research

Canada Foundation for Innovation

Fonds de Recherche du Québec - Santé

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12934/fullpdf

Reference23 articles.

1. Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant;Wiebe;Am J Transplant,2012

2. Diagnosis and management of antibody-mediated rejection: current status and novel approaches;Djamali;Am J Transplant,2014

3. Comparison of combination plasmapheresis/IVIg/anti-CD20 versus high-dose IVIg in the treatment of antibody-mediated rejection;Lefaucheur;Am J Transplant,2009

4. Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy;Lesage;Transplantation,2015

5. Cyclosporine sparing with mycophenolate mofetil, daclizumab and corticosteroids in renal allograft recipients: the CAESAR Study;Ekberg;Am J Transplant,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Betreuung von Patienten nach Nierentransplantation;Nephrologie aktuell;2024-09

2. Should we abandon therapeutic drug monitoring of tacrolimus in whole blood and move to intracellular concentration measurements?;British Journal of Clinical Pharmacology;2023-11-22

3. Expression of Class II Human Leukocyte Antigens on Human Endothelial Cells Shows High Interindividual and Intersubclass Heterogeneity;Journal of the American Society of Nephrology;2023-02-09

4. Efectos de la exposición a factores sensibilizantes y grado de sensibilización pretrasplante en el pronóstico del injerto renal;Revista Mexicana de Trasplantes;2023

5. Combined Analysis of HLA Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of De Novo Donor Specific Antibody Development in Kidney Transplant Recipients;International Journal of Molecular Sciences;2022-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3